Data only

Shows how the value changes over time · suggested for this question

Approvals

Annual FDA approvals of immune checkpoint inhibitors

After zero approvals in 2012 and 2013, authorized treatments surged to 7 per year in 2015 and 2016 before peaking at 13 in 2018.

Web search · verify8 values

The numbers

8 rows
Approvals (approvals). Source: The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors - PMC.
201813
201712
20167
20157
20142
20130
20120
20111

About this data

Where it's from
The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors - PMC
How it was found
Collected by grounded web search
Retrieved
Nov 14, 2026, 2:16 AM
Saved
14 Nov 2026

More charts

Browse every chart